Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Modellportföljen: Vi rensade ut den misslyckade Aiforia-investeringarna ur portföljen

AIFORIAResearch2026-09-02 09:00
Juha Kinnunen, Atte Riikola, Rauli Juva
Discuss

Automatisk översättning: Ursprungligen publicerad på finska 2026-09-02 07:00 GMT. Ge feedback här.

Vi har idag sålt Aiforia-aktierna från Modellportföljen, vilka hade en vikt på endast 1,0 %. I vår tillväxtinvestering med hög risk stannade tillväxten av, vilket spolierade vår ursprungliga investeringstes. Vi var medvetna om de höga riskerna förknippade med Aiforia vid tidpunkten för köpet, och tack vare en mindre positionsstorlek än vanligt förblev förlusterna begränsade i det stora hela, trots att aktien föll med hisnande över -70 % i Modellportföljen.

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures31/08

202526e27e
Revenue3.52.74.6
growth-%24.0 %-25.0 %75.0 %
EBIT (adj.)-11.2-13.2-10.4
EBIT-% (adj.)-316.3 %-497.3 %-224.9 %
EPS (adj.)-0.38-0.36-0.30
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

Could Aiforia practically already be a partner of Roche and Agilent through those companies’ acquisitions? Assuming those deals actually cross...
11 hours ago
6
Comments on the latest move LinkedIn #digitalpathology #ai #lifesciences #diagnostics | Paul Atkinson First Roche and PathAI. Now Agilent Technologies...
10/14/2026, 7:27 AM
by Vino Pino
16
thepathologist.com The Pathologist | Pathology Visions 2026 – Digital Pathology Conference Aiforia will also be featured there in a few days...
10/14/2026, 5:53 AM
by Salvelinus
11
Here are Antti’s comments regarding the acquisition of Aiforia’s partner by Agilent, a US-based laboratory and diagnostics company. The cash...
10/14/2026, 4:51 AM
by Sijoittaja-alokas
16
Here are Antti’s comments from when Aiforia signed the deal with PathAI. Aiforia announced on Thursday that it had entered into a commercial...
10/9/2026, 4:45 AM
by Sijoittaja-alokas
10
Domestic award for Aiforia: Messukeskuksessa juhlittiin suomalaisia maailmanluokan tekoälyratkaisuja – Opetushallitus ja Aiforia nappasivat ...
10/8/2026, 6:27 PM
by NukkeNukuttaja
16
Aiforia Enters into Collaboration with PathAI to Expand Access to AI-Powered Diagnostics Aiforia Enters into Collaboration with PathAI to Expand...
10/8/2026, 6:09 AM
by Kulkuri
30